Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Oparil

Showing results (11-20 of 368) with videos related to

Pageof 37
Sort By:
American Journal of Hypertension|June 2, 1998
Mibefradil, a T-channel-selective calcium antagonist: clinical trials in hypertensionS Oparil
Kidney International|September 1, 1986
The sympathetic nervous system in clinical and experimental hypertensionS Oparil
The American Journal of Cardiology|December 10, 1999
Candesartan cilexetil in combination with low-dose hydrochlorothiazide is effective in severe hypertensionS Oparil
Hypertension (Dallas, Tex. : 1979)|February 4, 1999
Arthur C. Corcoran Memorial Lecture. Hormones and vasoprotectionS Oparil
American Journal of Hypertension|December 2, 1998
The evolving role of angiotensin-II receptor blockers in cardiovascular risk reduction. Case studyS Oparil
Current Opinion in Nephrology and Hypertension|March 1, 1996
Antihypertensive therapy in the era of evidence based medical practice: what to do until the facts are inS Oparil
Comprehensive Therapy|December 1, 1975
Plasma renin activity in hypertensionS Oparil
American Journal of Hypertension|March 25, 1999
Management of the hypertensive patient with coronary artery diseaseS Oparil
The American Journal of Cardiology|October 10, 2001
Hypertension. IntroductionS Oparil
RN|March 1, 1976
Managing heart disease in pregnancyS Oparil
Pageof 37

Showing results (11-20 of 368) with videos related to

Sort By:
Pageof 37
American Journal of Hypertension|June 2, 1998
Mibefradil, a T-channel-selective calcium antagonist: clinical trials in hypertensionS Oparil
Kidney International|September 1, 1986
The sympathetic nervous system in clinical and experimental hypertensionS Oparil
The American Journal of Cardiology|December 10, 1999
Candesartan cilexetil in combination with low-dose hydrochlorothiazide is effective in severe hypertensionS Oparil
Hypertension (Dallas, Tex. : 1979)|February 4, 1999
Arthur C. Corcoran Memorial Lecture. Hormones and vasoprotectionS Oparil
American Journal of Hypertension|December 2, 1998
The evolving role of angiotensin-II receptor blockers in cardiovascular risk reduction. Case studyS Oparil
Current Opinion in Nephrology and Hypertension|March 1, 1996
Antihypertensive therapy in the era of evidence based medical practice: what to do until the facts are inS Oparil
Comprehensive Therapy|December 1, 1975
Plasma renin activity in hypertensionS Oparil
American Journal of Hypertension|March 25, 1999
Management of the hypertensive patient with coronary artery diseaseS Oparil
The American Journal of Cardiology|October 10, 2001
Hypertension. IntroductionS Oparil
RN|March 1, 1976
Managing heart disease in pregnancyS Oparil
Pageof 37